Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIVALIRUDIN vs BLEOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BIVALIRUDIN vs BLEOMYCIN: Safety Overview

Metric BIVALIRUDIN BLEOMYCIN
Total FAERS Reports 839 6,908
Deaths Reported 137 1,529
Death Rate 16.3% 22.1%
Hospitalizations 249 2,214
Average Patient Age 53.2 yrs 39.5 yrs
% Female Patients 33.7% 43.5%
FDA Approval Date Dec 15, 2000 Approved Prior to Jan 1, 1982
Manufacturer Meitheal Pharmaceuticals Inc. Hospira, Inc.
Route INTRAVENOUS INTRAMUSCULAR
Marketing Status Prescription Discontinued